BUSINESS Granules India completes cGMP audit at Chantilly site with four FDA observations Apr 4, 2026
Granules India shares drop 3.6% after receiving US FDA warning letter for Gagillapur facility Feb 28, 2025
Granules India says US FDA action may impact new product approvals, expect meet with FDA soon Dec 4, 2024
Granules India stock falls over 10% from day’s high as US FDA classifies inspection as “Official Action Indicated” Dec 3, 2024
Granules India shares surge 2% after US FDA grants ‘No Action Indicated’ status to Andhra Pradesh facility Nov 8, 2024